Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 1097
Aptamer sequence: CACATTAGGGCGGGGTACTCCTATCACGTATGGGGGCCTGT
Target unique ID: Other-44
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_1012 NB1 Other Activated protein C (APC) 20.2 nM 1X PBS 32486960
Structure information of aptamer
Aptamer Sequence: CACATTAGGGCGGGGTACTCCTATCACGTATGGGGGCCTGT
The optimal secondary structure in dot-bracket notation: .........(((((...(((((((.....))))))))))))
The centroid secondary structure in dot-bracket notation: .........(((((...(((((((.....))))))))))))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_1012 Description NB1
Aptamer chemistry DNA Length 41 nt
GC content 58.5% Molecular weight 12,673.12 Da
Molarity of 1 μg/μl solution 78.91 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence CACATTAGGGCGGGGTACTCCTATCACGTATGGGGGCCTGT
Applications G-NB3 inhibits the inactivation of activated cofactors V and VIII with IC50 values of 11.6 and 13.1 nM
Target information
Type Detail Type Detail
Target ID Other-44 Name Activated protein C (APC)
Activity data
Interaction ID 1097
Target type Other
Target unique ID Other-44
Activity 20.2 nM
Binding Conditions/Buffer

1X PBS

Assay

Influence of APC aptamers on the anticoagulant activity of endogenously generated APC in human plasma. Pooled normal citrated human plasma was spiked with rabbit thrombomodulin (2 U/mL) and increasing concentrations of APC aptamers. Subsequently, thrombin formation was measured using the CAT method

PubMed ID 32486960
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_1023 DNA CTCCTTCAACGAAGTGGGTCTCCTTCAACGAAGTGGGTCTC 58.54%
Apta_1040 DNA CAATTGGGCCCGTCCGTATGGTGGGT 58.54%
Apta_1095 DNA CCCTGAGGGGTGATGTGAATCCTAACAGTAAGGAGGAAGG 58.54%
Apta_148 DNA CCGTAGGTTCGGGGTCGGAGTGGTCCGGAAGGTGGCGTGG 56.10%
Apta_158 DNA CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTG 56.10%
Apta_1022 DNA CTCCTTCAACGAAGTGGGTTCCTTCAACGAAGTGGGTCTC 56.10%
Apta_344 DNA CACTACAGAGGTTGCGTCTGTCCCACGTTGTCATGGGGGGTTGGCCTG 54.17%
Apta_75 DNA CACTGGTAGGTTGGTGTGGTTGGGGCCAGTG 53.66%
Apta_149 DNA CCGTAGGTTCGGGGTCGGAGTGGTCCGGAAGATGGCGTGG 53.66%
Apta_150 DNA CCGTAGGTTCGGGGCGGAGTGGTCCGGAAGGTGGCGTGG 53.66%
Apta_258 DNA CACTGCGGGGGTCTATACGTGAGGAAGAAGTGGGCAGGTC 53.66%
Apta_263 DNA AGAGGGGAGGGTCGGGTATCGGCGTGTTCGGGGGATCTGC 53.66%
Apta_339 DNA CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTGT 53.66%
Apta_578 DNA CACCAAGCGCAGGGAATTACATTGAAGTGTGGGATTGGCT 53.66%
Apta_648 DNA GCACACCGATGGCGGTCCTGTTTAGGGGGTGTGC 53.66%
Apta_964 DNA CACGAGAGGGGTGAGGTGTCGTATTAGAGGGAAGCTCCAA 53.66%
Apta_1203 DNA CCCTGCGGGGCTACCCGATATGTGTCCGAGTGGTG 53.66%
Apta_735 DNA AGGCCCCCAGGCTCGGTGGATGCAAACACATGACTATGGGCCCGT 53.33%
Apta_79 DNA ATCTCGAGTCATAGGGGGCGCGAACATACGCGGTTGGTGTGGTTGGCTGACTCGT 52.73%
Apta_654 DNA GCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTG 51.85%